Trust Size
$130M
What Happened
European Biotech Acquisition Corp. filed its S-1 registration in 2021 and completed its business combination in 2023. The company was delisted from exchanges with 65 SEC filings on record.
European Biotech Acquisition Corp. entered the SPAC market in 2021 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
The company filed a definitive proxy statement (DEFM14A) ahead of its merger vote, completing its de-SPAC transaction in 2023.
SEC records show 65 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company's last SEC filing was 2023-03-13, and it appears to have been delisted from exchanges â a common fate for SPACs that fail to meet listing requirements or generate sufficient shareholder interest.
The company was incorporated in Cayman Islands.
Timeline
2021-03-08
S-1 Registration Filed
2023-02-03
Merger Proxy Filed (DEFM14A)
2023-03-13
Last SEC Filing
SEC Filing Details
CIK Number
1841258
Total SEC Filings
65
State of Incorporation
E9
Last Filing Date
2023-03-13
Business Location
Amsterdam, P7
Trust/Asset Size
$130M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for European Biotech Acquisition